PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target

Cambridge, UK, 18 Septem

Sapio Sciences partner program welcomes Astrix

Market leader in digital transformation and staffing services for science-based businesses becomes a Sapio Services Partner

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones

Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing

Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation

Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs

Appointment brings extensive regulatory experience as lead asset ETD001 progresses through Phase 2 clinical trial for treatment of cystic fibrosis

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes

Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and

NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman

Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of th

Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development

Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as pa

ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications

Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited, the CRISPR licensing Company, and Medicines Disco

Sapio Sciences advances the world's first AI-powered lab assistant

Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations

EPAM joins Sapio Sciences Partner Program

Global provider of digital engineering and development services to drive implementation of the Sapio Platform

Sapio Sciences and CREO Announce Strategic Partnership

Sapio Sciences and CREO to streamline laboratory management and digitally transform life science research

Bio-Rad launches Annexin V StarBright Conjugates for apoptosis detection via flow cytometry

Annexin V StarBright™ Conjugates Offer Increased Choice and Flexibility for Apoptosis Detection in Conventional and Full Spectrum Flow Cytometry

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series A funding round in February 2024

Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Investment in state-of-the-art imaging suite to accelerate data generation with physiologically-relevant in vitro models for deeper insights on drug effects in vivo Launch of advanced lung FMT assay provides extensive critical efficacy and safety data

Bio-Rad's study demonstrating utility of its SpyLock technology for fast generation and screening of bispecific antibodies

Study Describes Method to Successfully Modify the Functional Activity of SpyCatcher Protein for the Rapid Generation and High-Throughput Screening of Bispecific Antibodies

Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

Enables unique vector and process optimizations for different molecules to increase the likelihood of high titer clonal cell lines. Asimov now guarantees titers of 5 g/L for IgG monoclonal antibodies, as part of its Cell Line Development (CLD) Service

Sapio Sciences and Zifo announce strategic partnership

Industry leaders to provide world-class lab informatics platform, services and support to life science customers

Baltimore, MD, 30 July 2024 – Sapio Sciences, the science-aware™ lab informatics pla

Bio-Rad adds rapid bispecific antibody prototyping and screening services to Pioneer Antibody Discovery Platform

New service enables identification of bispecific antibody candidates accelerating drug development

Hercules, Calif.

CrestOptics’ CICERO spinning disk confocal system receives Top 10 Best Microscopy Innovation Award from Microscopy Today

Awards announced at Microscopy & Microanalysis Meeting, Cleveland, Ohio, 28th July – 1st August, 2024

Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge

New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and te

Bio-Rad outlines its advances leveraging droplet digital PCR in biopharma and translational research sectors

Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

Appointment of experienced preclinical CRO specialist to support accelerated expansion into key global markets

Cambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the specialist preclinical contract research organisation (CRO) and a leader

Enterprise Therapeutics doses first person with Cystic Fibrosis in Phase 2 Trial for novel therapy ETD001

Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 ETD001, a CFTR mutation agnostic approach to CF, is focussed on providing a novel treatment for members of the CF community that do not benefit f

Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson's disease Programme in collaboration with the Oxford Parkinson’s Disease Centre

Edinburgh, U